Antiferroptotic Drugs Reduce sFlt-1 Release and Placenta Damage in Preeclampsia
Hypertension. 2025 Aug 19. doi: 10.1161/HYPERTENSIONAHA.125.25003. Online ahead of print. ABSTRACT BACKGROUND: Preeclampsia is characterized by hypertension, proteinuria, and elevated antiangiogenic sFlt-1 (soluble fms-like tyrosine …